These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17113725)

  • 1. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
    Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
    Kamali-Sarvestani E; Talei AR; Merat A
    Cancer Lett; 2004 Nov; 215(1):83-7. PubMed ID: 15374636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
    Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
    Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
    Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 codon 72 polymorphism in breast cancer.
    Buyru N; Tigli H; Dalay N
    Oncol Rep; 2003; 10(3):711-4. PubMed ID: 12684648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
    Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
    Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
    Santos AM; Sousa H; Catarino R; Pinto D; Pereira D; Vasconcelos A; Matos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jun; 159(2):143-7. PubMed ID: 15899386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline polymorphism of p53 codon 72 in gynecological cancer.
    Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
    Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
    Wang YC; Chen CY; Chen SK; Chang YY; Lin P
    Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.